Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 1,108 shares at $26.76 ($30K) on 2026-05-18, disclosed to the SEC on 2026-05-19.
Seasonal sale ($30k) by CHIEF DEVELOPMENT OFFICER — this insider has traded KALV in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KALV | SELL | 2026-05-26 | $63K | — | Filing → |
| KALV | SELL | 2026-02-24 | $68K | — | Filing → |
| KALV | SELL | 2026-02-19 | $17K | — | Filing → |